cardiovascular

• “But most peoplescientists includedare astonished to realize that most of our antibiotics to combat infections, chemotherapy drugs against cancer, psychotropic drugs which modify mood disorders, and many advances in cardiovascular treatments and procedures were stumbled upon.”

  A Q&A with Morton A Meyers about Happy Accidents: Serendipity in Modern Medical Breakthroughs

• “The FDA rejected Contrave, from Orexigen and Takeda Pharmaceutical Co., late last month, requesting another clinical trial to study the drug's long-term cardiovascular risk.”

  The Wall Street Journal: Orexigen Cuts Jobs After Contrave Rejection

• “Others say that the more important contributor to the rise in cardiovascular disease is simply over-consumption of food, salty or not, and the obesity epidemic.”

  The Washington Post: Dietary Guidelines may reduce allowance for salt and sodium

• “If the Shanahans think Grossman is so superior in cardiovascular preparation and in the running of the two-minute offense that he gives them such a great chance to win, then go ahead and put Grossman out there full-time as the starter.”

  The Washington Post: Mike Shanahan's benching of Donovan McNabb is completely dumb

• “Orexigen said the FDA sent it a complete response letter outlining concerns about the long-term cardiovascular safety of the drug.”

  Forbes: Orexigen Tanks As FDA Nixes Obesity Drug Application

• “Obese children are at high risk for type 2 diabetes and cardiovascular disease but the contribution of childhood obesity to long-term cardiovascular risk, independent of adult weight, has never been clearly established, researchers said.”

  The Wall Street Journal: Losing Baby Fat Lowers Heart Risks Later

• “Patients taking Qnexa also achieved significant improvements in cardiovascular and metabolic risk factors including blood pressure, lipid levels, and type 2 diabetes.”

  Dr. Sharma’s Obesity Notes » Blog Archive » Obesity Combo-Drug Qnexa Reports Remarkable Phase III Results

• “- Significant improvements in cardiovascular, metabolic and inflammatory risk factors among patients treated with Qnexa;”

  Dr. Sharma’s Obesity Notes » Blog Archive » Obesity Combo-Drug Qnexa Reports Remarkable Phase III Results

• “Nevertheless, says Stephen Daniels, pediatrician-in-chief at Children ' s Hospital, Denver, the findings are part of an emerging and increasingly consistent picture where lifestyle starting early in life is a very important factor for long-term cardiovascular health.”

  The Wall Street Journal: Predicting Heart Health in Children

• “To do this, they relied only on insurance claims and hospitalization rates; they had no data on the prevalence of recurrent tonsillitis or long-term cardiovascular morbidity from obstructive sleep apnea.”

  The Wall Street Journal: In Defense of Physician Autonomy

Show 10 more examples...